… Geffen School of Medicine in the Department of Medicine, Division of Hematology … IMbrave-152/SKYSCRAPER-14 trial (NCT05904886), an ongoing randomized, placebo … a bevacizumab-containing backbone in advanced HCC. Given the evolving treatment landscape …

… the phase 3 TALENTACE trial (NCT04712643) presented during … and bevacizumab, suggesting a new and effective treatment option … , Xi’an International Medical Center Hospital, in … research grants from Shanghai Roche Pharmaceuticals, Co. Ltd; Bayer; …

… its mind and recommended the drug for use by the … later – if trifluridine-tipiracil with bevacizumab is not suitable – for adult … to the treatment within the UK, as the Scottish Medicines Consortium (SMC … the FRESCO and FRESCO-2 trials, which showed that it …

… April 2025 from the European Medicines Agency’s (EMA) … Committee for Medicinal Products for Human Use ( … reference drug Herceptin. Dazublys is indicated for the treatment of … approval for Bevqolva, a bevacizumab biosimilar, bringing its total …

… Park, MD, a medical oncologist at Norton Cancer … , in accessing clinical trials, which remain a … in the absence of trial availability or when … bevacizumab (Avastin); fruquintinib (Fruzaqla); and regorafenib (Stivarga). These agents offer viable treatment …

… from controlled clinical trial cohorts. Hepatocellular carcinoma … compared to controlled trials, the real-world … bevacizumab combination therapycancer treatment in Indiahepatocellular carcinoma treatmentimmunotherapy … and VEGF targeting drugsreal-world data …

… will make and supply the drug while Boryung, described as Korea … launched with Hanmi Pharmaceutical for postmenopausal osteoporosis. The drug entered the market … companies. Boryung also markets Onbevzi (bevacizumab), Samsung Bioepis’ Avastin biosimilar, which …

… , with or without bevacizumab, as dictated by … fostering adaptive clinical trial designs that incorporate … ovarian cancermulticenter clinical trials in Francenovel cancer … in cancer treatmentplatinum-based chemotherapy effectivenessprecision medicine in …

… the investigational antibody-drug conjugate telisotuzumab vedotin … phase 3 CLEOPATRA trial [NCT00567190] NCT00567190] … medications and improve treatment adherence. “Whether a medication … general medical oncologists are thinking FOLFIRI with bevacizumab [Avastin …

… [TAS-102; Lonsurf] and bevacizumab [Avastin] followed by fruquintinib … , the FDA approved fruquintinib for the treatment of adult … RAS wild-type and medically appropriate, an anti- … www.fda.gov/drugs/;resources-information-approved-drugs/fda-approves- …